Centerline Biomedical Stock

Centerline Biomedical, a Cleveland Clinic spin-off, is developing an innovative system

Sign up today and learn more about Centerline Biomedical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Centerline Biomedical Stock

Centerline Biomedical, Inc. was founded in November 2014 and is based on technology developed at the Cleveland Clinic. Centerline's mission is to develop advanced navigation systems that initially target interventional vascular procedures.

Funding History

August 2015$1.7M
September 2019$1.5M
March 2020$10.0M
April 2020$1.5M
June 2022$33.0M


Director of R&D and Regulatory Affairs

Jay Johnson

CTO , Operations ,Precision Care , Health IT for Minimally Invasive Surgery & Investor Relations

Vikash Goel

Chief Executive Officer

Gulam Khan


Jim Zalar

Scientific Advisor

Karl West

Business Advisory Board Member

Jay Johnson


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: